Arvinas (ARVN) EPS (Basic) (2017 - 2026)

Arvinas (ARVN) posted quarterly EPS (Basic) of -$0.9 for Q1 2026, down 178.71% year-over-year from $1.14 in Q1 2025, and up 5.33% quarter-over-quarter from -$0.95 in Q4 2025.

Arvinas (ARVN) EPS (Basic) (2017 - 2026) Analysis & Trends

Arvinas' EPS (Basic) history runs 10 years deep, the most recent figure standing at -$0.9 for Q1 2026.

  • In Q1 2026, EPS (Basic) fell 178.71% year-over-year to -$0.9; the TTM figure through Mar 2026 stood at -$3.46 (down 437.96% YoY), while the FY2025 annual figure was -$1.14, up 58.8% from the prior year.
  • EPS (Basic) for Q1 2026 stood at -$0.9, up from -$0.95 in the prior quarter.
  • The five-year high for EPS (Basic) was $1.14 in Q1 2025, with the low at -$2.79 in Q4 2023.
  • The 5-year median for EPS (Basic) is -$0.97 (2024), against an average of -$0.98.
  • The sharpest annual moves came in 2025 and 2026: EPS (Basic) soared 218.13% in 2025, then sank 178.71% in 2026.
  • Arvinas' EPS (Basic) stood at -$1.51 in 2022, then tumbled by 85.25% to -$2.79 in 2023, then soared by 77.51% to -$0.63 in 2024, then sank by 51.55% to -$0.95 in 2025, then increased by 5.33% to -$0.9 in 2026.
  • Business Quant data shows ARVN's EPS (Basic) at -$0.9 in Q1 2026, -$0.95 in Q4 2025, and -$0.48 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 12.62
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 7.59
4 Revolution Medicines 43.64 Bn 43.64 Bn - -3.06
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.16
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.18
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.23
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.06
10 Arvinas 585.74 Mn 17.84 Mn - 2.61

Historic Data

Download Data
DateValue
Jun 30, 2026 2.61
Mar 31, 2026 -0.90
Dec 31, 2025 -0.95
Sep 30, 2025 -0.48
Jun 30, 2025 -0.84
Mar 31, 2025 1.14
Dec 31, 2024 -0.63
Sep 30, 2024 -0.68
Jun 30, 2024 -0.49
Mar 31, 2024 -0.97
Dec 31, 2023 -2.79
Sep 30, 2023 -1.18
Jun 30, 2023 -1.22
Mar 31, 2023 -1.52
Dec 31, 2022 -1.51
Sep 30, 2022 -1.19
Jun 30, 2022 -1.27
Mar 31, 2022 -1.15
Dec 31, 2021 -0.92
Sep 30, 2021 -0.94